MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fphar.2024.1483792

Медицинская библиотека · Frontiers in pharmacology · 2025

Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus.

He Xu, Zhao Wei, Li PeiHang, Zhang YinJiang, Li GuoHua, Su HongYu, Lu BiNan, Pang ZongRan

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Glucagon-like peptide-1 (GLP-1) is a 30-amino acid intestinal insulin-stimulating factor, which is mainly secreted by L cells in the distal ileum and colon. It has various physiological functions, such as promoting insulin secretion and synthesis, stimulating β-cell proliferation, inducing islet regeneration, inhibiting β-cell apoptosis and glucagon release, delaying gastric emptying and controlling appetite, etc. It plays a role through a specific GLP-1 receptor (GLP-1R) distributed in many organs or tissues and participates in the regulation of glucose homeostasis in the body. GLP-1 receptor agonists (GLP-1RAs) has the similar physiological function of GLP-1. Because of its structural difference from natural GLP-1, it is not easy to be degraded by dipeptidyl peptidase-4 (DPP-4), thus prolonging the action time. GLP-1RAs have been recognized as a new type of hypoglycemic drugs and widely used in the treatment of type 2 diabetes mellitus (T2DM). Compared with other non-insulin hypoglycemic drugs, it can not only effectively reduce blood glucose and glycosylated hemoglobin (HbA1c), but also protect cardiovascular system, nervous system and kidney function without causing hypoglycemia and weight gain. Therefore, GLP-1RAs has good application prospects and potential for further development.

Для цитирования: He Xu, Zhao Wei, Li PeiHang, Zhang YinJiang, Li GuoHua, Su HongYu, Lu BiNan, Pang ZongRan. Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus.. Frontiers in pharmacology. 2025. DOI: 10.3389/fphar.2024.1483792.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.